(2021). Correction: Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: Mechanisms Underlying Low-clinical Responses to PD-1/PD-L1 Blocking Antibodies in Immunotherapy of Cancer: A Key Role of Exosomal PD-L1. BMJ Publishing Group, 2021.
MLA (8th ed.) CitationCorrection: Mechanisms Underlying Low-clinical Responses to PD-1/PD-L1 Blocking Antibodies in Immunotherapy of Cancer: A Key Role of Exosomal PD-L1. BMJ Publishing Group, 2021.
Warning: These citations may not always be 100% accurate.